Desq Long
Sign in
SEC FORM 4
—

BioNexus Gene Lab Corp (BGLC)

Acquisition (code A) of 338,709 shares; price not stated (see filing).

Reporting Person Tan Lee Su-Leng · Officer Title Chief Executive Officer · Transaction Code A

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001520138-26-000349 · filed 2026-08-14 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "BioNexus Gene Lab Corp (BGLC)." Disclosed 2026-08-14. https://desqlong.com/cards/0001520138-26-000349-1 (retrieved 2026-09-26).